Table 7.
Overall survival of the leukemic patients and its relation to different prognostic factors
| Cumulative survival at 24 month (%) | Median Survival (months) | p value | |
|---|---|---|---|
| Diagnosis | |||
| ALL | 47.4 | 23.5 | 0.518 |
| AML | 33.3 | 15.6 | |
| DFN (days) | |||
| <26.5 | 57.9 | 32.2 | |
| >26.5 | 35.4 | 16.5 | 0.024 |
| ANC (×109/L) | |||
| <0.13 | 15.6 | 16.5 | |
| ≥0.13 | 56.6 | 32.3 | 0.044 |
| Plt count (×109/L) | |||
| <39.5 | 14.7 | 16.5 | |
| ≥39.5 | 68.3 | 44.3 | 0.024 |
| ALC (×109/L) | |||
| <1.2 | 12.2 | 16.5 | 0.042 |
| ≥1.2 | 62.6 | 32.3 | |
| CMV score | |||
| <7 (n = 8) | 80.0 | 15.1 | 0.002 |
| ≥7 (n = 20) | 26.1% | 23.5 | |
| EBV PCR Serum | |||
| Positive (n = 9) | 68.6 | 91.6 | |
| Negative (n = 29) | 33.7 | 21.5 | 0.038 |
| CMV&EBV in serum | |||
| Both negative(n = 15) | 30.8 | 21.6 | 0.079 |
| CMV alone/EBV alone(n = 15) | 25.9 | 32.3 | |
| Both positive(n = 8) | 62.5 | 91.6 | |
Numerical factors were divided according to their median values
DFN Duration of febrile neutropenia, Plt platelets, ANC Absolute neutrophilic count, ALC Absolute lymphocytic count